Genprex Stock Performance
| GNPX Stock | USD 1.16 0.10 9.43% |
Genprex holds a performance score of 10 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of -1.25, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Genprex are expected to decrease by larger amounts. On the other hand, during market turmoil, Genprex is expected to outperform it. Use Genprex maximum drawdown, as well as the relationship between the skewness and day typical price , to analyze future returns on Genprex.
Risk-Adjusted Performance
10 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Genprex are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Genprex showed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 21 M |
Genprex |
Genprex Relative Risk vs. Return Landscape
If you would invest 39.00 in Genprex on September 16, 2024 and sell it today you would earn a total of 77.00 from holding Genprex or generate 197.44% return on investment over 90 days. Genprex is currently generating 5.2621% in daily expected returns and assumes 39.263% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Genprex, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Genprex Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Genprex's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Genprex, and traders can use it to determine the average amount a Genprex's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.134
| Best Portfolio | Best Equity | GNPX | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 39.26 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Genprex is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genprex by adding it to a well-diversified portfolio.
Genprex Fundamentals Growth
Genprex Stock prices reflect investors' perceptions of the future prospects and financial health of Genprex, and Genprex fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Genprex Stock performance.
| Return On Equity | -3.19 | ||||
| Return On Asset | -1.46 | ||||
| Current Valuation | 8.38 M | ||||
| Shares Outstanding | 8.51 M | ||||
| Price To Earning | (1.09) X | ||||
| Price To Book | 5.93 X | ||||
| EBITDA | (31.06 M) | ||||
| Cash And Equivalents | 25.52 M | ||||
| Cash Per Share | 0.53 X | ||||
| Total Debt | 3.25 M | ||||
| Debt To Equity | 1.11 % | ||||
| Book Value Per Share | 4.99 X | ||||
| Cash Flow From Operations | (24.74 M) | ||||
| Earnings Per Share | (10.69) X | ||||
| Total Asset | 10.67 M | ||||
| Retained Earnings | (133.69 M) | ||||
| Current Asset | 964.42 K | ||||
| Current Liabilities | 587.7 K | ||||
About Genprex Performance
Evaluating Genprex's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Genprex has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Genprex has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas. Genprex operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 22 people.Things to note about Genprex performance evaluation
Checking the ongoing alerts about Genprex for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Genprex help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Genprex is way too risky over 90 days horizon | |
| Genprex may become a speculative penny stock | |
| Genprex appears to be risky and price may revert if volatility continues | |
| Genprex has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (30.86 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Genprex currently holds about 25.52 M in cash with (24.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.53. |
- Analyzing Genprex's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Genprex's stock is overvalued or undervalued compared to its peers.
- Examining Genprex's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Genprex's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Genprex's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Genprex's stock. These opinions can provide insight into Genprex's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Genprex Stock Analysis
When running Genprex's price analysis, check to measure Genprex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genprex is operating at the current time. Most of Genprex's value examination focuses on studying past and present price action to predict the probability of Genprex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genprex's price. Additionally, you may evaluate how the addition of Genprex to your portfolios can decrease your overall portfolio volatility.